BD wasn't generating revenue for us, just validating the science. Our LymPro CLIA partner is doing a validation study in preparation for commercializing LymPro in their labs. Very different than the BD relationship.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
